The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
The Role of the Pentose Phosphate Pathway in Diabetes and Cancer
Open accessAbstract
The pentose phosphate pathway (PPP) branches from glucose 6-phosphate (G6P), produces NADPH and ribose 5-phosphate (R5P), and shunts carbons back to the glycolytic or gluconeogenic pathway. The PPP has been demonstrated to be a major regulator for cellular reduction-oxidation (redox) homeostasis and biosynthesis. Enzymes in the PPP are reported to play important roles in many human diseases. In this review, we will discuss the role of the PPP in type 2 diabetes and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
A guide to immunometabolism for immunologists
O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
Inflammatory mechanisms linking obesity and metabolic disease
Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212 · cited 2×
“Abnormally increased number and activity of ATMs as well as higher ratio of pro-inflammatory to anti-inflammatory macrophages are both hallmarks of obesityinduced inflammation (9).”
BackgroundReactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationThe metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 1×
“TP53-induced glycolysis and apoptosis regulator (TIGAR) enhances the PPP flux and biosynthesis (87).”
BackgroundThe return of metabolism: biochemistry and physiology of the pentose phosphate pathway
Stincone, A., Prigione, A., Cramer, T., Wamelink, M. M. C., Campbell, K., Cheung, E., Olin‐Sandoval, V., Grüning, N., Krüger, A., Tauqeer Alam, M., et al. (2015) · Biological Reviews · doi:10.1111/brv.12140 · Cited by 1,576
The pentose phosphate pathway and cancer
Patra, K. C., & Hay, N. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.06.005 · Cited by 1,432
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 1×
“When the PI3K/Akt signaling pathway is activated, NRF2 directly increases G6PD, 6PGD, TKT, and TALDO expression to enhance metabolic activities and promote cancer cell growth (58).”
BackgroundInsulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
Role of Glutathione in Cancer Progression and Chemoresistance
Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/972913 · Cited by 1,208
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180 · cited 2×
“Adipose tissue macrophages (ATMs) surrounding dead adipocytes cause obesity-induced inflammation and secrete pro-inflammatory cytokines leading to local insulin resistance in adipose tissues (8).”
BackgroundQuantitative flux analysis reveals folate-dependent NADPH production
Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B., & Rabinowitz, J. D. (2014) · Nature · doi:10.1038/nature13236 · Cited by 1,114
Molecular mechanisms of ROS production and oxidative stress in diabetes
Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R., & de Bittencourt, P. I. H. (2016) · Biochemical Journal · doi:10.1042/bcj20160503c · Cited by 878
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 795
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Perry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · cited 1×
“Both hepatic glucose production and proinflammatory cytokines contribute to hepatic insulin resistance (8, 17, 18).”
BackgroundGlucose‐6‐phosphate dehydrogenase, NADPH, and cell survival
Stanton, R. C. (2012) · IUBMB Life · doi:10.1002/iub.1017 · Cited by 701
Regulation of metabolism by the innate immune system
Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667
The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus
Gerber, P. A., & Rutter, G. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6755 · Cited by 654 · cited 1×
“Furthermore, long-term exposure to elevated levels of FFAs contributes to pancreatic β cells dysfunction and death (20, 21).”
BackgroundThe Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism
Haschemi, A., Kosma, P., Gille, L., Evans, C. R., Burant, C. F., Starkl, P., Knapp, B., Haas, R., Schmid, J. A., Jandl, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.023 · Cited by 635 · cited 1×
“CARKL is highly expressed in M2 macrophages and its down-regulation is critical for proper M1 polarization (33, 34) (Figure 2).”
BackgroundShukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.004 · Cited by 540
Diabetes, pancreatogenic diabetes, and pancreatic cancer
Andersen, D. K., Korc, M., Petersen, G. M., Eibl, G., Li, D., Rickels, M. R., Chari, S. T., & Abbruzzese, J. L. (2017) · Diabetes · doi:10.2337/db16-1477 · Cited by 516
Targeting Macrophages in Cancer: From Bench to Bedside
Poh, A. R., & Ernst, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00049 · Cited by 501
PPARδ regulates glucose metabolism and insulin sensitivity
Lee, C.-H., Olson, P., Hevener, A., Mehl, I., Chong, L.-W., Olefsky, J. M., Gonzalez, F. J., Ham, J., Kang, H., Peters, J. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511253103 · Cited by 497
McDonald, O. G., Li, X., Saunders, T., Tryggvadottir, R., Mentch, S. J., Warmoes, M. O., Word, A. E., Carrer, A., Salz, T. H., Natsume, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3753 · Cited by 494
Phosphoglycerate Mutase 1 Coordinates Glycolysis and Biosynthesis to Promote Tumor Growth
Hitosugi, T., Zhou, L., Elf, S., Fan, J., Kang, H.-B., Seo, J. H., Shan, C., Dai, Q., Zhang, L., Xie, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.020 · Cited by 432
Targeting innate immune mediators in type 1 and type 2 diabetes
Donath, M. Y., Dinarello, C. A., & Mandrup-Poulsen, T. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0213-9 · Cited by 416
The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
Riganti, C., Gazzano, E., Polimeni, M., Aldieri, E., & Ghigo, D. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.006 · Cited by 408
Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes
Lytrivi, M., Castell, A.-L., Poitout, V., & Cnop, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.09.016 · Cited by 408
Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S., & Thornalley, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2110 · Cited by 373
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Manne, V., Handa, P., & Kowdley, K. V. (2018) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.007 · Cited by 335
The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: A review
Wamelink, M. M. C., Struys, E. A., & Jakobs, C. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1015-6 · Cited by 330
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
Knapp, M., Tu, X., & Wu, R. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0042-6 · Cited by 328
Lin, R., Elf, S., Shan, C., Kang, H.-B., Ji, Q., Zhou, L., Hitosugi, T., Zhang, L., Zhang, S., Seo, J. H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3255 · Cited by 287
Self-citationO-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
Rao, X., Duan, X., Mao, W., Li, X., Li, Z., Li, Q., Zheng, Z., Xu, H., Chen, M., Wang, P. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms9468 · Cited by 257
Self-citationTransketolase counteracts oxidative stress to drive cancer development
Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., Law, C.-T., Wong, C.-M., Cai, Z., Wong, C. C.-L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508779113 · Cited by 251
Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
Dasgupta, S., Rajapakshe, K., Zhu, B., Nikolai, B. C., Yi, P., Putluri, N., Choi, J. M., Jung, S. Y., Coarfa, C., Westbrook, T. F., et al. (2018) · Nature · doi:10.1038/s41586-018-0018-1 · Cited by 250
TAp73 enhances the pentose phosphate pathway and supports cell proliferation
Du, W., Jiang, P., Mancuso, A., Stonestrom, A., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 233
Zhang, Z., Liew, C. W., Handy, D. E., Zhang, Y., Leopold, J. A., Hu, J., Guo, L., Kulkarni, R. N., Loscalzo, J., & Stanton, R. C. (2010) · The FASEB Journal · doi:10.1096/fj.09-136572 · Cited by 226
Xu, Y., Osborne, B. W., & Stanton, R. C. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00076.2005 · Cited by 213
Fructose Induces Transketolase Flux to Promote Pancreatic Cancer Growth
Liu, H., Huang, D., McArthur, D. L., Boros, L. G., Nissen, N., & Heaney, A. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4615 · Cited by 200
Zhao, F., Mancuso, A., Bui, T. V., Tong, X., Gruber, J. J., Swider, C. R., Sanchez, P. V., Lum, J. J., Sayed, N., Melo, J. V., et al. (2010) · Oncogene · doi:10.1038/onc.2010.67 · Cited by 179
Self-citationCytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging
Bradshaw, P. C. (2019) · Nutrients · doi:10.3390/nu11030504 · Cited by 178
Rabbani, N., Alam, S. S., Riaz, S., Larkin, J. R., Akhtar, M. W., Shafi, T., & Thornalley, P. J. (2009) · Diabetologia · doi:10.1007/s00125-008-1224-4 · Cited by 173
Mechanisms of the amplifying pathway of insulin secretion in the β cell
Kalwat, M. A., & Cobb, M. H. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.003 · Cited by 172
Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells
Ferdaoussi, M., Dai, X., Jensen, M. V., Wang, R., Peterson, B. S., Huang, C., Ilkayeva, O., Smith, N., Miller, N., Hajmrle, C., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82498 · Cited by 169 · cited 3×
“NADPH is one key modulator of the amplifying pathway because it converts GSSG to GSH which elicits insulin granule exocytosis via sentrin/SUMO-specific protease-1 (SENP1) (35, 36) (Figure 3).”
BackgroundInfluentialNagy, C., & Haschemi, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00164 · Cited by 166
TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
Cheng, J., Huang, Y., Zhang, X., Yu, Y., Wu, S., Jiao, J., Tran, L. M., Zhang, W., Liu, R., Zhang, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15819-3 · Cited by 164
Wu, S., Wang, H., Li, Y., Xie, Y., Huang, C., Zhao, H., Miyagishi, M., & Kasim, V. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-4047 · Cited by 163
Self-citationSheng, H., Li, Z., Su, S., Sun, W., Zhang, X., Li, L., Li, J., Liu, S., Lu, B., Zhang, S., et al. (2020) · Carcinogenesis · doi:10.1093/carcin/bgz152 · Cited by 159
Roumans, K. H. M., Lindeboom, L., Veeraiah, P., Remie, C. M. E., Phielix, E., Havekes, B., Bruls, Y. M. H., Brouwers, M. C. G. J., Ståhlman, M., Alssema, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15684-0 · Cited by 159
The differential role of reactive oxygen species in early and late stages of cancer
Assi, M. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00247.2017 · Cited by 158
Xu, X., Hausen, A. Z., Coy, J. F., & Löchelt, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24078 · Cited by 151
Lysine Acetylation Activates 6-Phosphogluconate Dehydrogenase to Promote Tumor Growth
Shan, C., Elf, S., Ji, Q., Kang, H., Zhou, L., Hitosugi, T., Jin, L., Lin, R., Zhang, L., Seo, J. H., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.020 · Cited by 147
Self-citationMa, X., Wang, L., Huang, D., Li, Y., Yang, D., Li, T., Li, F., Sun, L., Wei, H., He, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01647-5 · Cited by 146
Self-citationPoulain, L., Sujobert, P., Zylbersztejn, F., Barreau, S., Stuani, L., Lambert, M., Palama, T. L., Chesnais, V, Birsen, R., Vergez, F., et al. (2017) · Leukemia · doi:10.1038/leu.2017.81 · Cited by 145
Ham, M., Lee, J., Choi, A. H., Jang, H., Choi, G., Park, J., Kozuka, C., Sears, D. D., Masuzaki, H., & Kim, J. B. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01260-12 · Cited by 139
Summermatter, S., Baum, O., Santos, G., Hoppeler, H. H., & Handschin, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145995 · Cited by 134
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer
Wang, J., 袁伟杰, Chen, Z., Wu, S., 陈晋湘, Ge, J., Hou, F., & Chen, Z. (2011) · Tumor Biology · doi:10.1007/s13277-011-0251-9 · Cited by 129
SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation
Xu, S., Wang, T.-S., Li, X., & Wang, Y.-P. (2016) · Scientific Reports · doi:10.1038/srep32734 · Cited by 129
Self-citationFine-Needle Aspiration of Thyroid Nodules: Proteomic Analysis To Identify Cancer Biomarkers
Giusti, L., Iacconi, P., Ciregia, F., Giannaccini, G., Donatini, G. L., Basolo, F., Miccoli, P., Pinchera, A., & Lucacchini, A. (2008) · Journal of Proteome Research · doi:10.1021/pr8000404 · Cited by 125
Hong, X.-H., Song, R.-P., Song, H.-W., Zheng, T., Wang, J.-B., Liang, Y.-J., Qi, S., Lu, Z., Song, X., Jiang, H.-C., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305302 · Cited by 123
Liu, R., Li, W., Tao, B., Wang, X., Yang, Z., Zhang, Y., Wang, C., Liu, R., Gao, H., Liang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08921-8 · Cited by 123
Hanczko, R., Fernández, D., Doherty, E. H., Qian, Y., Vas, G., Niland, B. P., Caza, T. N., Garba, A. O., Banerjee, S. K., Middleton, F. A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35722 · Cited by 117
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity
Kim, O., Jun, W., & Lee, J. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000440905 · Cited by 115
Vizán, P., Alcarraz‐Vizán, G., Díaz‐Moralli, S., Solovjeva, O. N., Frederiks, W. M., & Cascante, M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24262 · Cited by 110
The Insulin Receptor: A New Target for Cancer Therapy
Malaguarnera, R., & Belfiore, A. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00093 · Cited by 110
Alkhalaf, A., Klooster, A., van Oeveren, W., Achenbach, U., Kleefstra, N., Slingerland, R. J., Mijnhout, G. S., Bilo, H. J. G., Gans, R. O. B., Navis, G., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2241 · Cited by 108
Spégel, P., Sharoyko, V. V., Göhring, I., Danielsson, A. P. H., Malmgren, S., Nagorny, C. L. F., Andersson, L. E., Koeck, T., Sharp, G. W. G., Straub, S. G., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121349 · Cited by 106
PGC-1α Improves Glucose Homeostasis in Skeletal Muscle in an Activity-Dependent Manner
Summermatter, S., Shui, G., Maag, D., Santos, G., Wenk, M. R., & Handschin, C. (2012) · Diabetes · doi:10.2337/db12-0291 · Cited by 104
Kowalik, M. A., Guzzo, G., Morandi, A., Perra, A., Menegon, S., Masgras, I., Trevisan, E., Angioni, M. M., Fornari, F., Quagliata, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8632 · Cited by 104
Katare, R., Caporali, A., Oikawa, A., Meloni, M., Emanueli, C., & Madeddu, P. R. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.903450 · Cited by 103
Qin, Z., Xiang, C., Zhong, F., Liu, Y., Dong, Q., Li, K., Shi, W., Ding, C., Qin, L., & He, F. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1131-1 · Cited by 102
Gadau, S. D., Emanueli, C., Linthout, S. V., Graiani, G., Todaro, M., Meloni, M., Campesi, I., Invernici, G., Spillmann, F., Ward, K., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0103-5 · Cited by 101
Qiu, Z., Guo, W., Wang, Q., Chen, Z., Huang, S., Zhao, F., Yao, M., Zhao, Y., & He, X. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.050 · Cited by 99
Zheng, W., Feng, Q., Liu, J., Guo, Y., Gao, L., Li, R., Xu, M., Yan, G., Yin, Z., Zhang, S., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00421 · Cited by 98
Gupte, R. S., Floyd, B. C., Kozicky, M., George, S., Ungvari, Z. I., Neito, V., Wolin, M. S., & Gupte, S. A. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.028 · Cited by 94
Benito, A., Polat, I. H., Noé, V., Ciudad, C. J., Marín, S., & Cascante, M. (2017) · Oncotarget · doi:10.18632/oncotarget.21601 · Cited by 94
Wang, J., Duan, Z., Nugent, Z. J., Zou, J. X., Borowsky, A. D., Zhang, Y., Tepper, C. G., Li, J. J., Fiehn, O., Xu, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.05.004 · Cited by 90
Maguire, D., Talwar, D. K., Shiels, P. G., & McMillan, D. C. (2018) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2018.02.007 · Cited by 85
Yen, W., Wu, Y., Wu, C., Lin, H., Stern, A., Chen, S., Shu, J., & Chiu, D. T.-Y. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101363 · Cited by 85
Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro
Chen, X., Xu, Z., Zhu, Z., Chen, A., Fu, G., Wang, Y., Pan, H., & Jin, B. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4501 · Cited by 79
Self-citationAdipokines and Hepatic Insulin Resistance
Yu, L. J., Ding, L., Hassan, W., Daoud, A., & Shang, J. (2013) · Journal of Diabetes Research · doi:10.1155/2013/170532 · Cited by 75
Li, M., Lu, Y., Li, Y., Tong, L., Gu, X., Meng, J., Zhu, Y., Wu, L., Feng, M., Tian, N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3776 · Cited by 74
Self-citationEmerging role of thiamine therapy for prevention and treatment of early‐stage diabetic nephropathy
Rabbani, N., & Thornalley, P. J. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01384.x · Cited by 72
A critical role of glucose-6-phosphate dehydrogenase in TAp73-mediated cell proliferation
Jiang, P., Du, W., & Yang, X. (2013) · Cell Cycle · doi:10.4161/cc.27267 · Cited by 71
Fraser, D. A., Diep, L. M., Hovden, I. A. H., Nilsen, K. B., Sveen, K. A., Seljeflot, I., & Hanssen, K. F. (2012) · Diabetes Care · doi:10.2337/dc11-1895 · Cited by 67
PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth
Zhang, X., Zhang, X., Li, Y., Shao, Y., Xiao, J., Zhu, G., & Li, F. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.85 · Cited by 67
Self-citationPentose phosphate pathway activity parallels lipogenesis but not antioxidant processes in rat liver
Jin, E. S., Lee, M. H., Murphy, R. E., & Malloy, C. R. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00342.2017 · Cited by 66
Hu, C., Wu, D., Bao, L., Yin, T., Lei, D., Yu, J., & Tong, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.028 · Cited by 66
Self-citationYang, X., Peng, X., & Huang, J. (2018) · Clinical and Translational Oncology · doi:10.1007/s12094-018-1833-4 · Cited by 59
G6PD Up-Regulation Promotes Pancreatic β-Cell Dysfunction
Lee, J.-W., Choi, A. H., Ham, M., Kim, J.-W., Choe, S. S., Park, J., Lee, G. Y., Yoon, K., & Kim, J. B. (2011) · Endocrinology · doi:10.1210/en.2010-0606 · Cited by 55
Ribose‐5‐phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling
Ciou, S., Chou, Y., Liu, Y., Nieh, Y., Lu, J., Huang, S.-F. K., Chou, Y., Cheng, L., Lo, J., Chen, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29361 · Cited by 53
Wang, C., Guo, K., Gao, D., Kang, X., Jiang, K., Li, Y., Sun, L., Zhang, S., Sun, C., Liu, X., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.031 · Cited by 50
Self-citationThe role of glucose-6-phosphate dehydrogenase in adipose tissue inflammation in obesity
Park, Y. J., Choe, S. S., Sohn, J. H., & Kim, J. B. (2017) · Adipocyte · doi:10.1080/21623945.2017.1288321 · Cited by 50
Prognostic significance of G6PD expression and localization in lung adenocarcinoma
Nagashio, R., Oikawa, S., Yanagita, K., Hagiuda, D., Kuchitsu, Y., Igawa, S., Naoki, K., Satoh, Y., Ichinoe, M., Murakumo, Y., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.05.005 · Cited by 50
Chan, B., VanderLaan, P. A., & Sukhatme, V. P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.08.048 · Cited by 49
G6PD promotes renal cell carcinoma proliferation through positive feedback regulation of p-STAT3
Zhang, Q., Yang, Z., Han, Q., Bai, H., Wang, Y., Yi, X., Yi, Z., Yang, L., Jiang, L., Song, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22566 · Cited by 48
Self-citationTian, N., Liu, Q., Li, Y., Tong, L., Lu, Y., Zhu, Y., Zhang, P., Chen, H., Hu, L., Meng, J., et al. (2020) · Diabetes · doi:10.2337/db19-1087 · Cited by 48
Self-citationHigh glucose–induced ubiquitination of G6PD leads to the injury of podocytes
Wang, M., Hu, J., Yan, L., Yang, Y., He, M., Wu, M., Qin, L., Gong, W., Yang, Y., Wang, Y., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801921r · Cited by 46
Self-citationBhanot, H., Weisberg, E., Reddy, M. M., Nonami, A., Neuberg, D. S., Stone, R. M., Podar, K., Salgia, R., Griffin, J. D., & Sattler, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18797 · Cited by 40
Chou, Y., Jiang, J., Yang, M., Lu, J., Lin, H.-K., Wang, H., & Yuh, C. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2003714 · Cited by 39
Ding, Y., Gong, C., Huang, D., Chen, R., Sui, P., Lin, K., Liang, G., Yuan, L., Xiang, H., Chen, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06651-x · Cited by 39
Cha, Y. J., Jung, W. H., & Koo, J. S. (2017) · Disease Markers · doi:10.1155/2017/7062517 · Cited by 38
Guo, H., Xiang, Z., Zhang, Y., & Sun, D. (2019) · Clinical and Translational Oncology · doi:10.1007/s12094-018-1937-x · Cited by 34
Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers
Britovšek, N. K., Odreman, F., Vindigni, A., Grazio, S. F., & Komel, R. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i11.1216 · Cited by 30
Kong, D., Li, S., Du, Z., Liu, C., Liu, B.-Q., Li, C. R., Zong, Z., & Wang, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6396 · Cited by 29
Chou, Y., Chen, L.-Y., Tsai, S., Tu, H., Lu, J., Ciou, S., Wang, H., & Yuh, C. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy155 · Cited by 29
Glucose-6-phosphate dehydrogenase contributes to the regulation of glucose uptake in skeletal muscle
Lee, R. S., Hoffman, N. J., Murphy, K. T., Henstridge, D. C., Samocha‐Bonet, D., Siebel, A. L., Iliades, P., Zivanovic, B., Hong, Y. H., Colgan, T. D., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.09.002 · Cited by 25
Cited by
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
“Sedoheptulokinase is expressed by M2-like macrophages in vitro and downregulated to allow proinflammatory M1-like macrophage features [206].”
BackgroundCytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging
Bradshaw, P. C. (2019) · Nutrients · doi:10.3390/nu11030504 · Cited by 178
The central moTOR of metabolism
Simcox, J., & Lamming, D. W. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.024 · Cited by 174
Itraconazole inhibits tumor growth via CEBPB‐mediated glycolysis in colorectal cancer
Zhang, Y., Li, L., Chu, F., Wu, H., Xiao, X., Ye, J., & Li, K. (2024) · Cancer Science · doi:10.1111/cas.16082 · Cited by 19
“…shown that glycolysis and PPPs as well as pyruvate metabolism are significantly enhanced in tumors, thus providing energy and the substances required for biosynthesis for tumor cell proliferation and metastasis, 25,26 and providing new evidence for treating CRC tumors by inhibiting these pathways.”
Background
Metadata
- Authors
- Ge, T., Yang, J., Zhou, S., Wang, Y., Li, Y., & Tong, X.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-09
- Volume
- 11
- Pages
- 365-365
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W3032976905
- Cited by
- 409
- References
- 118
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.